Dipna Pharmachem Limited

As of March 31, 2026, Dipna Pharmachem Limited carries a market capitalization of 210.84M, placing it among publicly traded companies globally. Its enterprise value stands at 331.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Dipna Pharmachem Limited has 26.29M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Dipna Pharmachem Limited maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Dipna Pharmachem Limited recorded 442,000.00 in income tax expense.

As of the close on October 22, 2026, Dipna Pharmachem Limited's stock has declined approximately 80.07% over the past 52 weeks. The 50-day moving average sits at 4.90, while the 200-day moving average is 8.34.

As of March 31, 2026, Dipna Pharmachem Limited holds 11.92M in cash and equivalents against 132.11M in total debt, resulting in a net debt position of 123.48M. Total book value stands at 623.03M, with working capital of 208.64M providing operational flexibility.

Dipna Pharmachem Limited's most recent stock split took place on February 12, 2024 with a 129:157 split ratio.